002826 易明医药
交易中 09-14 13:09:00
资讯
新帖
简况
股市必读：易明医药新发布《关于回购公司股份比例达到2%及回购实施结果暨股份变动的公告》
证券之星 · 02:47
股市必读：易明医药新发布《关于回购公司股份比例达到2%及回购实施结果暨股份变动的公告》
易明医药（002826）披露回购公司股份比例达到2%及回购实施结果暨股份变动的公告，9月11日股价下跌3.28%
证券之星 · 09-11 22:29
易明医药（002826）披露回购公司股份比例达到2%及回购实施结果暨股份变动的公告，9月11日股价下跌3.28%
易明医药(002826)8月31日股东户数1.7万户，较上期减少4.42%
证券之星 · 09-07
易明医药(002826)8月31日股东户数1.7万户，较上期减少4.42%
易明医药：累计回购股份比例达1.07% 达回购资金下限
格隆汇 · 09-04
易明医药：累计回购股份比例达1.07% 达回购资金下限
股市必读：易明医药新发布《关于股份回购进展情况的公告》
证券之星 · 09-04
股市必读：易明医药新发布《关于股份回购进展情况的公告》
易明医药（002826）披露股份回购进展公告，9月2日股价上涨2.57%
证券之星 · 09-02
易明医药（002826）披露股份回购进展公告，9月2日股价上涨2.57%
股市必读：易明医药(002826)股东户数1.78万户，较上期减少0.41%
证券之星 · 08-31
股市必读：易明医药(002826)股东户数1.78万户，较上期减少0.41%
易明医药：截至2026年8月20日，本公司股东数为17,825户
证券之星 · 08-28
易明医药：截至2026年8月20日，本公司股东数为17,825户
易明医药（002826）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-28
易明医药（002826）2026年中报简析：营收净利润同比双双增长，盈利能力上升
易明医药(002826)8月10日股东户数1.79万户，较上期增加11.53%
证券之星 · 08-27
易明医药(002826)8月10日股东户数1.79万户，较上期增加11.53%
易明医药(002826.SZ)发布半年度业绩，归母净利润6667.97万元，同比上升77.54%
智通财经 · 08-26
易明医药(002826.SZ)发布半年度业绩，归母净利润6667.97万元，同比上升77.54%
图解易明医药中报：第二季度单季净利润同比增长150.66%
证券之星 · 08-26
图解易明医药中报：第二季度单季净利润同比增长150.66%
股市必读：易明医药新发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》
证券之星 · 08-24
股市必读：易明医药新发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》
易明医药（002826）披露回购股份事项前十名股东持股情况，8月20日股价上涨3.07%
证券之星 · 08-20
易明医药（002826）披露回购股份事项前十名股东持股情况，8月20日股价上涨3.07%
股市必读：易明医药新发布《关于首次回购公司股份的公告》
证券之星 · 08-19
股市必读：易明医药新发布《关于首次回购公司股份的公告》
易明医药：截至2026年8月10日股东数为17,899户
证券之星 · 08-18
易明医药：截至2026年8月10日股东数为17,899户
股市必读：易明医药新发布《关于首次回购公司股份的公告》
证券之星 · 08-18
股市必读：易明医药新发布《关于首次回购公司股份的公告》
股市必读：易明医药新发布《关于回购公司股份方案的公告》
证券之星 · 08-17
股市必读：易明医药新发布《关于回购公司股份方案的公告》
易明医药最新公告：拟3500万元至7000万元回购公司股份
证券之星 · 08-14
易明医药最新公告：拟3500万元至7000万元回购公司股份
易明医药：截至2026年8月10日股东数为17,899户
证券之星 · 08-14
易明医药：截至2026年8月10日股东数为17,899户
加载更多
公司概况
公司名称：
西藏易明西雅医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2016-12-09
主营业务：
西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是米格列醇片、红金消结片、蒙脱石散、醋氯芬酸肠溶片、多潘立酮片。公司为西藏药学会第七届理事会理事单位、国家级科技企业孵化企业、西藏经开区优秀企业。
发行价格：
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":17.24,"timestamp":1789362540000,"preClose":17.12,"halted":0,"volume":1425500,"delay":0,"changeRate":0.007,"floatShares":185000000,"shares":191000000,"eps":0.6383,"marketStatus":"交易中","change":0.12,"latestTime":"09-14 13:09:00","open":17.15,"high":17.4,"low":17.03,"amount":24519000,"amplitude":0.0216,"askPrice":17.25,"askSize":117,"bidPrice":17.23,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.6383,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789369200000},"marketStatusCode":2,"adr":0,"adjPreClose":17.12,"symbolType":"stock","openAndCloseTimeList":[[1789349400000,1789356600000],[1789362000000,1789369200000]],"highLimit":18.83,"lowLimit":15.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":3.78,"roa":"--","peRate":27.009243,"roe":"7.85%","epsLYR":0.5,"committee":-0.159664,"marketValue":3287000000,"turnoverRate":0.0077,"status":0,"floatMarketCap":3185000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2667680095","title":"股市必读：易明医药新发布《关于回购公司股份比例达到2%及回购实施结果暨股份变动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667680095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667680095?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:47","pubTimestamp":1789325230,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至9月11日，易明医药回购股份3,944,245股，占总股本2.0685%，回购金额69,984,064.00元，回购方案已实施完毕。公司公告汇总关于回购公司股份比例达到2%及回购实施结果暨股份变动的公告西藏易明西雅医药科技股份有限公司于2026年8月13日召开董事会，审议通过回购公司股份方案，拟使用自有资金以集中竞价方式回购股份，用于股权激励或员工持股计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517578","title":"易明医药（002826）披露回购公司股份比例达到2%及回购实施结果暨股份变动的公告，9月11日股价下跌3.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517578","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666517578?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:29","pubTimestamp":1789136982,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，易明医药报收于17.12元，较前一交易日下跌3.28%，最新总市值为32.64亿元。近日，西藏易明西雅医药科技股份有限公司发布《关于回购公司股份比例达到2%及回购实施结果暨股份变动的公告》。公告显示，公司于2026年8月13日召开董事会，审议通过回购公司股份方案，拟使用自有资金以集中竞价方式回购股份，用于股权激励或员工持股计划。本次回购符合相关法规及公司既定方案，回购期间相关主体无买卖公司股票行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665314855","title":"易明医药(002826)8月31日股东户数1.7万户，较上期减少4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665314855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665314855?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:48","pubTimestamp":1788774517,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年8月31日公司股东户数为1.7万户，较8月20日减少788.0户，减幅为4.42%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.65万户。从股价来看，2026年8月20日至2026年8月31日，易明医药区间跌幅为1.97%，在此期间股东户数减少788.0户，减幅为4.42%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664933584","title":"易明医药：累计回购股份比例达1.07% 达回购资金下限","url":"https://stock-news.laohu8.com/highlight/detail?id=2664933584","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664933584?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:54","pubTimestamp":1788515668,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380683","title":"股市必读：易明医药新发布《关于股份回购进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380683","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664380683?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:43","pubTimestamp":1788457389,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至8月31日，易明医药已回购股份1,041,800股，占总股本0.5464%，累计回购金额18,221,120.00元，进展符合方案要求。公司公告汇总关于股份回购进展情况的公告西藏易明西雅医药科技股份有限公司于2026年8月13日召开董事会，审议通过回购公司股份方案，拟使用自有资金以集中竞价方式回购股份，用于股权激励或员工持股计划，回购金额不低于3,500万元且不超过7,000万元，价格不超过25.74元/股，实施期限为董事会审议通过之日起12个月内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817788","title":"易明医药（002826）披露股份回购进展公告，9月2日股价上涨2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817788","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664817788?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:30","pubTimestamp":1788359433,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，易明医药报收于17.96元，较前一交易日上涨2.57%，最新总市值为34.25亿元。该股当日开盘17.34元，最高18.36元，最低17.33元，成交额达1.32亿元，换手率为4.02%。近日，易明医药披露《关于股份回购进展情况的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663238590","title":"股市必读：易明医药(002826)股东户数1.78万户，较上期减少0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663238590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663238590?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:27","pubTimestamp":1788136030,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，易明医药报收于17.2元，下跌0.86%，换手率1.36%，成交量2.51万手，成交额4328.69万元。当日关注点交易信息汇总：8月28日主力资金净流出413.5万元，占总成交额9.55%。股本股东变化股东户数变动截至2026年8月20日公司股东户数为1.78万户，较8月10日减少74.0户，减幅为0.41%。户均持股数量为1.07万股，户均持股市值为19.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662405316","title":"易明医药：截至2026年8月20日，本公司股东数为17,825户","url":"https://stock-news.laohu8.com/highlight/detail?id=2662405316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662405316?lang=zh_cn&edition=full","pubTime":"2026-08-28 11:33","pubTimestamp":1787888001,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)08月27日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月20日股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年8月20日，本公司股东数为17,825户，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800023785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039980","title":"易明医药（002826）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039980","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039980?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:29","pubTimestamp":1787869767,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期易明医药发布2026年中报。截至本报告期末，公司营业总收入3.6亿元，同比上升15.47%，归母净利润6667.97万元，同比上升77.54%。按单季度数据看，第二季度营业总收入1.77亿元，同比上升8.67%，第二季度归母净利润4703.13万元，同比上升150.66%。本报告期易明医药盈利能力上升，毛利率同比增幅1.4%，净利率同比增幅53.02%。本文数据来源于易明医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703453","title":"易明医药(002826)8月10日股东户数1.79万户，较上期增加11.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703453","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703453?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:11","pubTimestamp":1787825463,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年8月10日公司股东户数为1.79万户，较7月31日增加1850.0户，增幅为11.53%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年7月31日至2026年8月10日，易明医药区间涨幅为10.43%，在此期间股东户数增加1850.0户，增幅为11.53%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662274850","title":"易明医药(002826.SZ)发布半年度业绩，归母净利润6667.97万元，同比上升77.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662274850","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662274850?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:56","pubTimestamp":1787756209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药 发布2026年半年度报告，报告期内，公司实现营业收入3.6亿元，同比上升15.47%;归属于上市公司股东净利润6667.97万元，同比上升77.54%;归属于上市公司股东的扣除非经常性损益的净利润4164.28万元，同比上升66.42%;基本每股收益0.36元。2026年上半年，公司实施双线并行的经营发展战略，统筹做好存量业务守护与增量业务开拓。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"易明医药(002826.SZ)发布半年度业绩，归母净利润6667.97万元，同比上升77.54%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662713075","title":"图解易明医药中报：第二季度单季净利润同比增长150.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662713075","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662713075?lang=zh_cn&edition=full","pubTime":"2026-08-26 19:13","pubTimestamp":1787742788,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药2026年中报显示，上半年度公司主营收入3.6亿元，同比上升15.47%；归母净利润6667.97万元，同比上升77.54%；扣非净利润4164.28万元，同比上升66.42%；其中2026年第二季度，公司单季度主营收入1.77亿元，同比上升8.67%；单季度归母净利润4703.13万元，同比上升150.66%；单季度扣非净利润2236.62万元，同比上升51.26%；负债率27.82%，投资收益174.32万元，财务费用-77.0万元，毛利率82.02%。财报数据概要请见下图:本文数据来源于易明医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600043223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245293","title":"股市必读：易明医药新发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661245293?lang=zh_cn&edition=full","pubTime":"2026-08-24 03:52","pubTimestamp":1787514731,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，易明医药报收于17.34元，下跌2.47%，换手率2.17%，成交量4.01万手，成交额6962.28万元。当日关注点交易信息汇总：8月21日主力资金净流出388.65万元，占总成交额5.58%。公司公告汇总：公司于8月13日董事会审议通过回购股份方案，并披露回购决议前一交易日的前十名股东及前十名无限售条件股东持股情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660826233","title":"易明医药（002826）披露回购股份事项前十名股东持股情况，8月20日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660826233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660826233?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:45","pubTimestamp":1787237115,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，易明医药报收于17.78元，较前一交易日上涨3.07%，最新总市值为33.9亿元。该股当日开盘17.6元，最高18.18元，最低17.6元，成交额达1.06亿元，换手率为3.21%。近日，易明医药发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》。公告显示，公司于2026年8月13日召开董事会，审议通过回购公司股份方案；现披露董事会公告回购股份决议前一交易日登记在册的前十名股东及前十名无限售条件股东的持股情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491101","title":"股市必读：易明医药新发布《关于首次回购公司股份的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491101","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491101?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:49","pubTimestamp":1787078950,"startTime":"0","endTime":"0","summary":"公司公告汇总：易明医药于2026年8月17日首次回购股份125,000股，成交金额2,230,082元。董秘最新回复投资者： 董秘您好，请问公司截止2026年08月20日的最新股东人数是多少人？董秘： 尊敬的投资者，您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年8月10日，本公司股东数为17,899户，感谢关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660554468","title":"易明医药：截至2026年8月10日股东数为17,899户","url":"https://stock-news.laohu8.com/highlight/detail?id=2660554468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660554468?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:12","pubTimestamp":1787040742,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司截止2026年08月20日的最新股东人数是多少人？谢谢！易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年8月10日，本公司股东数为17,899户，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800026408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431084","title":"股市必读：易明医药新发布《关于首次回购公司股份的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431084","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660431084?lang=zh_cn&edition=full","pubTime":"2026-08-18 02:18","pubTimestamp":1786990694,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，易明医药报收于17.84元，上涨0.96%，换手率2.63%，成交量4.86万手，成交额8599.23万元。公司公告汇总：易明医药于8月17日首次回购股份125,000股，成交金额2,230,082元。公司公告汇总关于首次回购公司股份的公告西藏易明西雅医药科技股份有限公司于2026年8月17日首次通过股份回购专用证券账户以集中竞价交易方式回购公司股份125,000股，占公司总股本0.07%，最高成交价17.91元/股，最低成交价17.79元/股，成交总金额2,230,082元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800002291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170188","title":"股市必读：易明医药新发布《关于回购公司股份方案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170188?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:10","pubTimestamp":1786903821,"startTime":"0","endTime":"0","summary":"公司公告汇总关于回购公司股份方案的公告西藏易明西雅医药科技股份有限公司拟使用自有资金以集中竞价方式回购公司股份，回购资金总额不低于3,500万元且不超过7,000万元，回购价格不超过25.74元/股；回购股份拟用于股权激励或员工持股计划，预计回购股份数量1,359,752至2,719,502股，约占公司总股本的0.71%至1.43%；回购期限为董事会审议通过之日起12个月内；相关股东在回购期间暂无减持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143652","title":"易明医药最新公告：拟3500万元至7000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143652","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659143652?lang=zh_cn&edition=full","pubTime":"2026-08-14 18:40","pubTimestamp":1786704034,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)公告称，公司拟使用自有资金以集中竞价方式回购股份，回购资金总额不低于3500万元且不超过7000万元，回购价格不超过25.74元/股。按回购金额上限测算，预计回购股份约272万股，占公司总股本的1.43%；按下限测算，预计回购约136万股，占总股本的0.71%。回购股份将用于股权激励或员工持股计划，实施期限为自董事会审议通过之日起12个月内。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400033166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152112","title":"易明医药：截至2026年8月10日股东数为17,899户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152112?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:00","pubTimestamp":1786698048,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月0日公司股东人数是多少，谢谢！易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年8月10，本公司股东数为17,899户，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400027924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789362542419,"stockEarnings":[{"period":"1week","weight":-0.0333},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.1153},{"period":"6month","weight":-0.2067},{"period":"1year","weight":-0.1309},{"period":"ytd","weight":-0.0595}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16894人(较上一季度减少0.84%)","perCapita":"10934股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是米格列醇片、红金消结片、蒙脱石散、醋氯芬酸肠溶片、多潘立酮片。公司为西藏药学会第七届理事会理事单位、国家级科技企业孵化企业、西藏经开区优秀企业。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}